top of page

September 2021 // Communication

Updated: Oct 25, 2021

Top 100 Swiss Startup Award 2021

We are honored to be selected as one of the TOP 100 Swiss Startups 2021 and particularly proud to announce that Synendos won TOP 100 Swiss Startup Public Voting Award 2021 in the category Biotech! The full Top 100 list can be found

We are grateful to all our team, supporters and partners for making this achievement possible!

Recent Posts

See All

January 2024 // Company & Communication

Synendos granted EMA Clinical Trial Authorisation for first-in-class Endocannabinoid System modulator, SYT-510. Synendos transitions to a clinical-stage biotech company developing innovative Endocanna

July 2023 // Communication

Synendos Therapeutics AG announces that co-founder and Scientific Advisor Board member, Professor Jürg Gertsch, presented groundbreaking new findings on an endocannabinoid transporter at the 10th Gord

bottom of page